Image from Google Jackets

Melanoma : molecular biology, risk factors and treatment options [E-Book]

Contributor(s):

Jones, Alexander C [editor.]

Series: Dermatology--laboratory and clinical research series | Cancer etiology, diagnosis, and treatmentsPublisher: New York : Nova Biomedical, [2013]Description: 1 online resourceContent type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9781628086119
1628086114

Subject(s):

Online resources:

Access resource

Contents:

""MELANOMA: MOLECULAR BIOLOGY, RISK FACTORS AND TREATMENT OPTIONS""; ""MELANOMA: MOLECULAR BIOLOGY, RISK FACTORS AND TREATMENT OPTIONS""; ""Library of Congress Cataloging-in-Publication Data""; ""Contents""; ""Preface""; ""Chapter 1: Melanoma Progression to Metastatic Disease: The Role of the PI3K/AKT and Wnt/�Ip2(B-Catenin Pathways""; ""Abstract""; ""1. PI3K/AKT Signaling Pathway and Its Components""; ""1.1. Overview""; ""1.2. Components of the PI3K Pathway""; ""1.2.1. PI3K Isoforms""; ""1.2.2. Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN)""; ""1.2.3. AKT""

""1.3. PI3K Pathway Activation and Downstream Targets""""1.4. PI3K in Cancer""; ""2. PI3K Pathway in Melanoma""; ""2.1. Melanoma""; ""2.1.1. Overview""; ""2.1.2. Stages of Melanoma""; ""2.1.3. Melanoma and Common Mutations of Signaling Pathways""; ""2.2. PI3K and Melanoma Progression""; ""3. PI3K Mediated Crosstalk in Melanoma Progression""; ""3.1. PI3K �a�? MAPK Crosstalk""; ""ERK 1/2 Module""; ""JNK Module""; ""3.2. PI3K �a�? NF-�IºB Cross Talk""; ""3.3. PI3K �a�? TGF�Ip2 (BPathway Crosstalk""; ""3.4. PI3K �a�? Notch Pathway Crosstalk""; ""3.5. PI3K �a�? JAK-STAT Pathway Crosstalk""

""3.6. PI3K- mTOR Crosstalk""""4. Wnt/�Ip2(B-Catenin and PI3K Pathway""; ""4.1. �Ip2(B-Catenin""; ""4.1.1. Structure and Function""; ""At Cellular Membrane""; ""In the Cytoplasm and Nucleus""; ""4.1.2. �Ip2(B-Catenin/Canonical Wnt Pathway""; ""4.1.3. Active �Ip2(B-Catenin""; ""4.1.4. Localization""; ""4.1.5. �Ip2(B-Catenin in Cancer""; ""4.1.6. �Ip2(B-Catenin in Melanoma""; ""4.2. Crosstalk between the PI3K and Canonical Wnt Pathways in Melanoma Progression""; ""4.2.1. GSK3�Ip2 (BAs a Potential Candidate to Mediate Crosstalk between Wnt/�Ip2(B-Catenin and PI3K Pathways""

""4.2.2. Other Potential Candidates That Mediate Crosstalk between Wnt/�Ip2(B-Catenin and PI3K Pathways""""4.2.2.1. AKT""; ""4.2.2.2. PI3K""; ""4.2.2.3. mTOR""; ""4.2.2.4. TGF�Ip2(B1""; ""Current Therapeutics of Melanoma and Concluding Remarks""; ""References""; ""Chapter 2: Cutaneous Melanoma: Molecular Biology, Risk Factors and Treatment Options""; ""Abstract""; ""1. The Biology of Cutaneous Melanoma""; ""1.1. Risk Factors""; ""1.2. Development of Cutaneous Melanoma""; ""1.2.1. Models for heterogeneity in Cutaneous Melanoma""

""1.2.2. Pathways Involved in Cutaneous Melanoma Development and Progression""""Cell Proliferation and Angiogenesis Pathways""; ""Pigment Synthesis Pathways""; ""1.3. Cutaneous Melanoma and the Immune System""; ""The theory of Cancer Immunoediting""; ""Evidences of immunoediting in Cutaneous Melanoma""; ""2. Cutaneous Melanoma Treatment and Management""; ""2.1. Targeted Therapies""; ""2.2. Immunotherapy""; ""2.2.1. Therapeutic Vaccines""; ""2.2.2. Our Experience with Therapeutic Vaccines""; ""Therapeutic Vaccines of Irradiated Allogeneic Cutaneous Melanoma Cells""

Summary: Melanoma accounts for only 4% of all skin cancer cases but most of skin cancer-related death. The rising incidence of melanoma makes this tumor an important public health problem. In this book, the authors present current research in the study of the molecular biology, risk factors and treatment options for melanoma. Topics include the role of P13K/AKT and Wnt/<U+00dd>-Catenin pathways in melanoma's progression to metastatic disease; cutaneous melanoma; molecular determinants of melanoma vasculogenic mimicry; new aspects of the molecular biology of melanoma metastasis; the surgical extent of regional.

Holdings
Item type	Home library	Class number	URL	Status	Date due	Barcode
Electronic book	Stenhouse Library (Kingston Hospital) Online		Link to resource	Available

Includes bibliographical references and index.

Melanoma accounts for only 4% of all skin cancer cases but most of skin cancer-related death. The rising incidence of melanoma makes this tumor an important public health problem. In this book, the authors present current research in the study of the molecular biology, risk factors and treatment options for melanoma. Topics include the role of P13K/AKT and Wnt/<U+00dd>-Catenin pathways in melanoma's progression to metastatic disease; cutaneous melanoma; molecular determinants of melanoma vasculogenic mimicry; new aspects of the molecular biology of melanoma metastasis; the surgical extent of regional.

OCLC control number change

There are no comments on this title.

to post a comment.

Storage	Name	Value	Expiration	Description
Cookie	CGISESSID	Session ID	Until logout or end of session	Session cookie
Cookie	KohaOpacLanguage	Language code	3 years	Stores the language the user selected, so the online catalog will appear in that same language the next time it is visited.
Cookie	form_serialized form_serialized_limits	Search terms and limits	End of session or when the advanced search page is accessed again.	jQuery cookie. Stores search terms and limits of the last advanced search. Set when an advanced search is submitted.
Cookie	search_path_code	ads (fewer) or exs (more)	End of session or when the advanced search page is accessed again.	jQuery cookie. Related to serialized_form* cookies. Stores if the advanced search form was used with 'More options' or 'Fewer options'.
Cookie	num_paragraph	Count of search options added	End of session or when the advanced search page is accessed again.	jQuery cookie. Used to store the number of created options when user selects 'More options' in advanced search to increase search boxes.
Cookie	bib_list	List of record IDs (biblionumbers) separated by /	End of session or until the cart is emptied.	Stores cart contents in the online catalog. Set when records are added to the cart for the first time.